Your browser doesn't support javascript.
loading
"Lazarus Response" to Olaparib in a Virtually Chemonaive Breast Cancer Patient Carrying Gross BRCA2 Gene Deletion.
Moiseyenko, Vladimir M; Chubenko, Vyacheslav A; Moiseyenko, Fedor V; Zagorskaya, Lyudmila A; Zaytseva, Yuliya A; Gesha, Nataliya E; Zykov, Evgeny N; Ni, Valeriya I; Preobrazhenskaya, Elena V; Sokolenko, Anna P; Imyanitov, Evgeny N.
Affiliation
  • Moiseyenko VM; Director, City Cancer Center, Saint Petersburg.
  • Chubenko VA; Department of Chemotherapy, City Cancer Center, Saint Petersburg.
  • Moiseyenko FV; Department of Chemotherapy, City Cancer Center, Saint Petersburg.
  • Zagorskaya LA; Department of Chemotherapy, City Cancer Center, Saint Petersburg.
  • Zaytseva YA; Department of Chemotherapy, City Cancer Center, Saint Petersburg.
  • Gesha NE; Department of Chemotherapy, City Cancer Center, Saint Petersburg.
  • Zykov EN; Laboratory of Nuclear Diagnostics, City Cancer Center, Saint Petersburg.
  • Ni VI; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg.
  • Preobrazhenskaya EV; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg.
  • Sokolenko AP; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg.
  • Imyanitov EN; Department of Tumor Growth Biology, N.N. Petrov Institute of Oncology, Saint Petersburg.
Cureus ; 10(2): e2150, 2018 Feb 04.
Article in En | MEDLINE | ID: mdl-29651367
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2018 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cureus Year: 2018 Document type: Article Country of publication: Estados Unidos